Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
74.26%
Operating Margin
73.10%
Net Margin
47.55%
Efficiency Metrics
Revenue per Expense Ratio
3.63
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
73.98%
Income Tax Rate
0.50%
EPS
11.1100000000
Balance Sheet Analysis
Current Ratio
0.62
Cash Ratio
0.62
Working Capital
$-228.99M
Debt to Equity
0.91
Debt to Assets
45.95%
Equity Ratio
50.55%
Cash Flow Analysis
Operating Cash Flow Ratio
71.87%
Free Cash Flow Ratio
61.66%
CapEx to Revenue
10.21%
Dividends Paid
$2.31B
Stock Buybacks
$53.13M
Total Shareholder Returns
$2.36B
Cash Position Change
-50.27%
Detailed Growth Metrics
Core Performance
Revenue
8.02%
Net Income
-50.60%
EPS
-70.40%
Operating Income
52.22%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
12.50%
Operating Cash Flow
4.15%
Free Cash Flow
4.82%
Balance Sheet Health
Assets
12.86%
Debt
32.49%
Book Value per Share
-0.71%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-41.10%
Shares Outstanding
0.12%
Long Term Trends
3Y Revenue/Share
54.11%
5Y Revenue/Share
62.31%
3Y Dividend/Share
42.71%
5Y Dividend/Share
41.73%